Thursday, June 08, 2023 11:12:12 AM
Honi soit qui mal y pense
In current French usage, the phrase may be used ironically to imply the presence of a hidden agenda or a conflict of interest.[1]
https://en.wikipedia.org/wiki/Honi_soit_qui_mal_y_pense
The motto appears on a representation of the garter, surrounding the Shield of the Royal coat of arms of the United Kingdom used outside Scotland.
The motto appears in a royal coat of arms of the 17th century on the ceiling of Bath Abbey.
Honi soit qui mal y pense (UK: /??ni ?sw?? ki? ?mæl i? 'p?~s/, US: /- ?m??l -/, French: [?ni swa ki mal i p?~s]) is a maxim in the Anglo-Norman language, a dialect of Old Norman French spoken by the medieval ruling class in England, meaning "shamed be whoever thinks ill of it", usually translated as "shame on anyone who thinks evil of it".[1] It is the motto of the British chivalric Order of the Garter, the highest of all British knighthoods, except in Scotland.[2]
In current French usage, the phrase may be used ironically to imply the presence of a hidden agenda or a conflict of interest.[1]
https://en.wikipedia.org/wiki/Honi_soit_qui_mal_y_pense
The motto appears on a representation of the garter, surrounding the Shield of the Royal coat of arms of the United Kingdom used outside Scotland.
The motto appears in a royal coat of arms of the 17th century on the ceiling of Bath Abbey.
Honi soit qui mal y pense (UK: /??ni ?sw?? ki? ?mæl i? 'p?~s/, US: /- ?m??l -/, French: [?ni swa ki mal i p?~s]) is a maxim in the Anglo-Norman language, a dialect of Old Norman French spoken by the medieval ruling class in England, meaning "shamed be whoever thinks ill of it", usually translated as "shame on anyone who thinks evil of it".[1] It is the motto of the British chivalric Order of the Garter, the highest of all British knighthoods, except in Scotland.[2]
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
